|
Drug
Proving now termed, as Homoeopathic Pathogenetic Trials (HPT) is a process in
which drug substances are put into trial over healthy volunteers and their
pathogenetic effects are observed and noted for therapeutic purposes. Therefore,
it is the only and unique method, which is based on the nature’s law of cure
i.e., Similia Similibus Curentur which
states that likes are cured by likes i.e. a drug’s capacity for eradicating a
disease, lies in its capacity to produce the same.
Since the
discovery of Homoeopathy, the process and methodology of HPTs has improved
greatly. In this effort, Council has also developed a plan and protocol of
double blind technique in Drug Proving. Process of symptom extraction from HPTs
has also been standardized. Success of this methodology can be assessed from the
Clinical Verification studies of proving pathogenesis where many symptoms have
been repeatedly verified when prescriptions are based upon them. Such symptoms
are being reflected in the reports of Clinical Verification programme under
individual drugs.
METHODOLOGY
The
drug proving is conducted under Drysdale’s Double Blind Technique where
neither the Proving Master nor the Prover knows the name of the drug and its
potencies being proved on them. The drug is proved on healthy human beings
selected from different regions of the country in order to ascertain whether
ecological, socio-economic, climatic, regional factors & food habits,
variation in physical constitution of the volunteers affect the drug
pathogenesis in any form. A drug is proved at more than one centre. The healthy
volunteers are selected on the basis of pre-trial medical examination conducted
by Honorary Consultants in the field of Medicine, Psychiatry, Ophthalmology,
Otorhino-laryngology, Dermatology, Pathology and Gynaecology (in case of female
provers). Drugs are provided to the provers in coded phials and provers are
divided into two groups, one receives `placebo’ and other `actual drug’ to
distinguish between the false and true symptoms. The Proving Master records the
responses of the provers in the prescribed proforma. The data collected during
the course of provings is received at the Central Drug Proving-cum-Data
Processing Cell at the Headquarters office of the Council, where it is
processed, analyzed and compiled and later on published for the use of the
profession.
ACHIEVEMENTS
Drugs Proved so
far
|
1.
|
Abroma
augusta folia
|
|
2.
|
Acalypha
indica
|
|
3.
|
Acid
butyricum
|
|
4.
|
Acorus
calamus
|
|
5.
|
Aegle
folia
|
|
6.
|
Aegle
marmelos
|
|
7.
|
Agave
Americana
|
|
8.
|
Alfalfa
|
|
9.
|
Androgrographis
paniculata
|
|
10.
|
Aranea
diadema
|
|
11.
|
Aranea
scinencia
|
|
12.
|
Argemone
mexicana
|
|
13.
|
Arsenicum
bromicum
|
|
14.
|
Atista
indica
|
|
15.
|
Azadirachta
indica
|
|
16.
|
Bacopa
monniere
|
|
17.
|
Baryta
iodata
|
|
18.
|
Bellis
perennis
|
|
19.
|
Boerhaavia
diffusa
|
|
20.
|
Calotropis
gigantea
|
|
21.
|
Carica
papaya
|
|
22.
|
Cassia
fistula
|
|
23.
|
Cassia
sophera
|
|
24.
|
Cephalandra
indica
|
|
25.
|
Chelone
|
|
26.
|
Chromo
kali sulph
|
|
27.
|
Clerodendron
infortunatum
|
|
28.
|
Coleus
aromaticus
|
|
29.
|
Cornus
circinata
|
|
30.
|
Cup.
oxydatum nigrum
|
|
31.
|
Curcuma
longa
|
|
32.
|
Cuscuta
reflexa
|
|
33.
|
Cynodon
dactylon
|
|
34.
|
Embelia
ribes
|
|
35.
|
Euphorbia
lathyris
|
|
36.
|
Ficus
religiosa
|
|
37.
|
Formic
acid
|
|
38.
|
Glycyrrhiza
glabra
|
|
39.
|
Holarrhena
antidysenterica
|
|
40.
|
Hydrocotyle
asiatica
|
|
41.
|
Ichthyolum
|
|
42.
|
Juglans
regia
|
|
43.
|
Kali
muriaticum
|
|
44.
|
Lapis
alba
|
|
45.
|
Leucas
aspera
|
|
46.
|
Liatris
spicata
|
|
47.
|
Magnesia
sulphuricum
|
|
48.
|
Mangifera
indica
|
|
49.
|
Mimosa
humalis
|
|
50.
|
Mygale
|
|
51.
|
Nyctanthes
arbortristis
|
|
52.
|
Ocimum
canum
|
|
53.
|
Ocimum
sanctum
|
|
54.
|
Oxytropis
lamberti
|
|
55.
|
Paraffin
|
|
56.
|
Phyllanthus
niruri
|
|
57.
|
Pothos
foetidus
|
|
58.
|
Pyrus
Americana
|
|
59.
|
Rauwolfia
serpentina
|
|
60.
|
Ricinus
communis
|
|
61.
|
Saraca
indica
|
|
62.
|
Senega
|
|
63.
|
Skookum
chuck
|
|
64.
|
Staphylococcinum
|
|
65.
|
Tarentula
cubensis
|
|
66.
|
Tarentula
hispanica
|
|
67.
|
Tela
aranea
|
|
68.
|
Terminalia
arjuna
|
|
69.
|
Terminalia
chebula
|
|
70.
|
Thea
chinensis
|
|
71.
|
Theridion
|
|
72.
|
Thymol
|
|
73.
|
Thyroidinum
|
|
74.
|
Tinospora
cordifolia
|
|
75.
|
Tribulus
terrestris
|
|
76.
|
Tylophora
indica
|
Compilation
of 08 drugs has been completed and 06 drugs are under compilation.
Publications :
Proving data of the drugs
proved by the Council is published from time to time for the use of the
profession in the form of monographs or in Quarterly Bulletin/Indian Journal of
Research in Homoeopathy.
Monographs of following drugs
have been published containing data on Drug Proving, Drug Standardization
(involving pharmacognostic, pharmacological and physico-chemical studies) &
clinically verified symptoms.
|
1.
|
Abroma
augusta folia
|
|
2.
|
Kali
muriaticum
|
|
3.
|
Cassia
sophera
|
|
4.
|
Cynodon
dactylon
|
|
5.
|
Aegle
folia
|
|
6.
|
Aegle
marmelos
|
|
7.
|
Hydrocotyle
asiatica
|
|
8.
|
Atista
indica
|
|
9.
|
Carica
papaya
|
|
10.
|
Terminalia
chebula
|
|
11
|
Boerhaavia
diffusa
|
1.
‘Homoeopathic Drug Provings’
2.
‘Homoeopathic Drug Proving’, (Volume 2)
3.
Protocol on Homoeopathic Pathogenetic Trial (Drug Proving) 2007
·
Articles on other drugs proved by the Council and published
in the Bulletin/ Indian Journal of
Research in Homoeopathy. :
|
Sl.
No.
|
Name
of the drugs
|
No.&
Issue of Quarterly Bulletin/IJRH.
|
|
1.
|
Cassia
sophera
|
Q. B.
Vol. 2 (2), 1980
|
|
2.
|
Baryta
iodatum
|
Q. B.
Vol. 2 (3), 1980
|
|
3.
|
Cynodon
dectylon
|
Q. B.
Vol. 2 (4), 1980
|
|
4.
|
Kali
muriaticum
|
Q. B.
Vol. 3 (1), 1981
|
|
5.
|
Formic
acidum
|
Q. B.
Vol. 7 (4), 1985
|
|
6.
|
Cuprum
oxydatum nigrum
|
Q. B.
Vol. 7 (1-4), 1985
|
|
7.
|
Aegle
folia
|
Q. B.
Vol.9 (3-4), 1987(Drug
Proving Special I)
|
|
8.
|
Aranea
diadema
|
-do-
|
|
9.
|
Boerhaavia
diffusa
|
-do-
|
|
10.
|
Hydrocotyle
asiatica
|
-do-
|
|
11.
|
Mygale
|
-do-
|
|
12.
|
Tarentula
cubensis
|
-do-
|
|
13.
|
Tarentula
hispanica
|
-do-
|
|
14.
|
Aegle
marmelos
|
Q. B.
Vol. 12 (1-2), 1990 (Drug Proving Special II)
|
|
15.
|
Aranea
scinencia
|
-do-
|
|
16.
|
Atista
indica
|
-do-
|
|
17.
|
Cassia
fistula
|
-do-
|
|
18.
|
Tela
aranea
|
-do-
|
|
19.
|
Thea
chinensis
|
-do-
|
|
20.
|
Azadirachta
indica
|
Q. B.
Vol. 13 (1-2), 1991
|
|
21.
|
Tylophora
indica
|
-do-
|
|
22.
|
Curcuma
longa
|
-do-
|
|
23.
|
Holarrhena
antidysenterica
|
Q. B.
Vol.15 (1-2), 1993
|
|
24.
|
Terminalia
arjuna
|
-do-
|
|
25.
|
Terminalia
chebula
|
-do-
|
|
26.
|
Embelia
ribes
|
Q. B.
Vol. 17 (3-4), 1995
|
|
27.
|
Lapis
alba
|
-do-
|
|
28.
|
Thymol
|
-do-
|
|
29.
|
Acalypha
indica
|
Q. B.
Vol. 18 (1-2), 1996
|
|
30.
|
Theridion
|
-do-
|
|
31.
|
Mag.
sulph
|
Q. B.
Vol. 19 (1-2), 1997(Drug
Proving Special-III)
|
|
32.
|
Glycyrrhiza
glabra
|
-do-
|
|
33.
|
Mangifera
indica
|
-do-
|
|
34.
|
Phyllanthus
niruri
|
-do-
|
|
35.
|
Carica papaya
|
-do-
|
|
36.
|
Nyctanthes
arbortristis
|
-do-
|
|
37.
|
Terminalia
chebula
|
-do-
|
|
38.
|
Acid
butyricum
|
Q. B.
Vol. 24 (3-4), 2003(Drug
Proving Special-IV)
|
|
39.
|
Arsenicum
bromatum
|
-do-
|
|
40.
|
Chromo
kali sulph
|
-do-
|
|
41.
|
Euphorbia
lathyris
|
-do-
|
|
42.
|
Ocimum
can
|
-do-
|
|
43.
|
Oxytropis
lamberti
|
-do-
|
|
44.
|
Rauwolfia
serpentina
|
-do-
|
|
45.
|
Ricinus
communis
|
-do-
|
|
46.
|
Staphylococcinum
|
-do-
|
|
47.
|
Tribulus
terrestris
|
-do-
|
|
48.
|
Alfalfa
|
Q. B.
Vol. 26 (2), 2004
|
|
49.
|
Bellis
perennis
|
Q. B.
Vol. 26 (3), 2004
|
|
50.
|
Calotropis
gigantea
|
Q. B.
Vol. 26 (4), 2004
|
|
51.
|
Ichthyolum
|
Q. B.
Vol. 27 (1), 2005
|
|
52.
|
Pyrus
americana
|
Q. B.
Vol. 27 (2), 2005
|
|
53.
|
Tarentula
hispanica
|
Q. B.
Vol. 27 (3), 2005
|
|
54.
|
Agave
americana
|
IJRH,
Vol. 1, No. 1 2007
|
|
